TY - JOUR
T1 - Chemoprevention of contralateral breast cancer with the synthetic retinoid fenretinide
AU - Veronesi, Umberto
AU - Costa, Alberto
PY - 1988
Y1 - 1988
N2 - The Milan Cancer Institute has been involved in clinical research on breast cancer for the last 25 years, and although the previous studies have been mainly concerned with trials aimed at refining the chemotherapy, radiotherapy, and surgical procedures, in recent years we have been progressively interested in detection and prevention programs. In this latter context, we have developed a special interest in research in chemoprevention with retinoids.
AB - The Milan Cancer Institute has been involved in clinical research on breast cancer for the last 25 years, and although the previous studies have been mainly concerned with trials aimed at refining the chemotherapy, radiotherapy, and surgical procedures, in recent years we have been progressively interested in detection and prevention programs. In this latter context, we have developed a special interest in research in chemoprevention with retinoids.
UR - http://www.scopus.com/inward/record.url?scp=0024240433&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024240433&partnerID=8YFLogxK
U2 - 10.3109/07357908809082135
DO - 10.3109/07357908809082135
M3 - Article
AN - SCOPUS:0024240433
SN - 0735-7907
VL - 6
SP - 639
EP - 641
JO - Cancer Investigation
JF - Cancer Investigation
IS - 5
ER -